Manx Financial Group (FRA:3IM) Research & Development: €0.00 Mil (TTM As of Dec. 2025)


FRA:3IM Manx Financial Group PLC FRA:3IM
47 GF Score
Price €0.30
GF Value €0.27
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Manx Financial Group Research & Development?

Manx Financial Group FRA:3IM +1.37% 47 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:3IM with a GF Score™ of 47/100 and a GF Value™ of €0.27 (Fairly Valued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Manx Financial Group's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Manx Financial Group  (FRA:3IM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Manx Financial Group Research & Development Related Terms

Manx Financial Group Research & Development Historical Data

* Premium members only.

The historical data trend for Manx Financial Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manx Financial Group Research & Development Chart

Manx Financial Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Manx Financial Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:3IM
47GF Score
Manx Financial Group PLC FRA:3IM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manx Financial Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Manx Financial Group (FRA:3IM) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Manx Financial Group and its competitors.
Is Manx Financial Group's Research & Development too high?
Manx Financial Group's current Research & Development is €0.00 Mil. Overall, Manx Financial Group has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Manx Financial Group's Research & Development compare to PNC and USB?
Manx Financial Group's Research & Development of €0.00 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Manx Financial Group and its competitors. Manx Financial Group's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manx Financial Group stock overvalued right now?
Based on GuruFocus' analysis, Manx Financial Group (FRA:3IM) is currently considered Fairly Valued. The stock's GF Value™ is €0.27, compared to a current price of €0.30 — trading 9.6% above its estimated fair value. The current Research & Development is €0.00 Mil. Manx Financial Group's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Manx Financial Group (FRA:3IM), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Manx Financial Group (FRA:3IM) Overvalued in 2026?

Based on GuruFocus' analysis, Manx Financial Group stock appears to be overvalued. The current stock price of €0.30 is trading 9.6% above its estimated GF Value™ of €0.27. GuruFocus considers Manx Financial Group to be Fairly Valued.

Key valuation signals for FRA:3IM:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.27 vs. price of €0.30 (9.6% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the FRA:3IM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Manx Financial Group Business Description

Other Exchanges MFX:UK
Address Victoria Street, Clarendon House, Douglas, IMN, IM1 2LN
Manx Financial Group PLC is a banking company. The group along with its subsidiaries offers retail and commercial banking services, payment solutions, wealth management, general insurance, and life insurance. It operates in three product orientated segments along with investing activities: Asset and Personal Finance (including provision of HP contracts, finance leases, personal loans, commercial loans, block discounting, vehicle stocking plans and wholesale funding agreements); Edgewater Associates Limited (provision of financial advice); and MFX Limited (provision of foreign currency transaction services). The Group currently operates in one geographic segment comprising of the Isle of Man, and UK region.
47GF Score

Get the complete analysis for FRA:3IM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price
€0.27
GF Value